Viral Safety of Plasma-derived Blood Products. I. Efficiency of Virus Inactivation/Elimination during Manufacturing Process of Monoclonal Antibody-purified Freeze-Dried Coagulation Factor VIII Concentrate(CROSS EIGHT M).